Monographie - Levofolinate calcium

Zadnji put ažurirano :
08/05/2024

Levofolinate calcium

Kemijska struktura

Nekomercijalni

Zaštićeni nazivi su indikativni i sastav ekscipijensa može biti različit ovisno o državi i laboratorijima

Calc Levof	Italija
Calcium levofolinat	Austrija
Elvorine	Belgija, Francuska, Luksemburg, Maroko
Folaxin	Španjolska
Folinate EG	Belgija
Isovorin	Austrija, Danska, Finska, Grčka, Island, Španjolska, Švedska, Velika Britanija
Levofolatino de calcio	Portugal
Levofolene	Italija

Bibliografija : Levofolinate calcium

	Vrsta	Publikacija
3	Časopis	Trissel LA, Martinez JF. Compatibility of amifostine with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 1995 ; 52: 2208-2212.
155	Časopis	Trissel LA, Martinez JF, Xu QA. Incompatibility of fluorouracil with leucovorin calcium or levoleucovorin calcium. Am J Health-Syst Pharm 1995 ; 52: 710-715.
1520	Laboratorija	Etude de stabilité des médicaments en Ecoflac® B Braun 2001
1914	Laboratorija	Pemetrexed (Alimta®) - Summary of Product Characteristics Eli Lilly 2016
2130	Časopis	Lokiec F, Amirault P, Bonnans H, Gauzan MF, Sauvage N, Santoni J. Stabilité du mélange 5-fluoro-uracil-acide fonique : influence des concentrations, du contenant et de la forme de l’acide folinique. Bull Cancer 1999 ; 86, 11: 946-954.
2181	Časopis	Milano G, Renée N. Etude de compatibilité physicochimique 5- fluoro-uracile (nouvelle préparation française) - acide folinique. Bull Cancer 1995 ; 82: 189-195.
2295	Laboratorija	Fosaprepitant (Emend®) - Summary of Product Characteristics Merck Sharp Dohme 2013
2361	Časopis	Lebitasy M, Hecq J.D, Athanassopoulos A, Vanbeckbergen D, Jamart J, Galanti L. Effect of freeze-thawing on the long-term stability of calcium levofolinate in 5% dextrose stored on polyolefin infusion bags. J Clin Pharm Ther 2009 ; 34, 4 : 423-428.
2531	Časopis	Sanogo S, Silimbani P, Gaggeri R, Masini C. Stability of calcium levofolinate reconstituted in syringes and diluted in NaCl 0.9% and glucose 5% polyolefin/ polyamide infusion bags. J Oncol Pharm Practice 2021 ; 27, 2: 288-296.
3369	Laboratorija	Levofolinate de sodium Medac - Résumé des caractéristiques du produits MEDAC France 2011
3523	Laboratorija	Ceftriaxone (Rocephin®) - Summary of Product Characteristics. Roche 2018
3546	Laboratorija	Cefamandole Flavelab - Résumé des caractéristiques du produit Panpharma SA 2007
3619	Laboratorija	Pamidronate (Pamidronate Actavis®) - Summary of Product Characteristics Wockhardt 2016
3621	Laboratorija	Phosphate dipotassique - Résumé des caractéristiques du produit Renaudin 2008
3662	Laboratorija	Foscavir (Foscarnet®) - Summary of Product Characteristics Clinigen 2014
3753	Laboratorija	Tedizolid phosphate (Sivextro®) - Summary of Product Characteristics Cubist Pharmaceuticals 2014
3838	Laboratorija	Magnesium Sulphate - Summary of Product Characteristics Martindale Pharmaceuticals Ltd 2007
3933	Laboratorija	Acide zolédronique - (Acide zoledronique Teva Pharma) - Résumé des caractéristiques du produit Teva Laboratoire 2015
4154	Laboratorija	Bleomycin sulfate- Summary of Product Characteristics Accord Health Care 2018
4720	Laboratorija	Nuzyra (amadacycline - Full prescribing infomation. Paratek Pharmaceuticals updated May 2021. Paratek Pharmaceuticals 2021

Mentions Légales